Sensus Healthcare Announces the Sale/Install of its 500th Unit
Mid-Atlantic Skin Surgery Institute in Maryland acquires a second SRT systemBOCA RATON, FL, April 13, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective...
Colorado State University, Flint Animal Cancer Center Applies Sensus Healthcare’s SRT Non-Surgical Treatment to Animal Care
Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options in veterinary settings BOCA RATON, Fla, March 16, 2021 -- Sensus Healthcare, Inc. (Nasdaq:...
Sensus Healthcare to Participate in Three Investment Conferences During the Month of March
BOCA RATON, Fla, March 08, 2021 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that...
Sensus Healthcare Reports Fourth Quarter and Full Year 2020 Financial Results
Achieves fourth quarter net income of $1.0 million on revenues of $5.1 million Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 25, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,...
Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X-Ray Source
Patent covers beam splitting and sculpting capabilities of radiation to treat all types of solid tumors with Sculptura™ and potentially other devicesBOCA RATON, Fla, Feb. 23, 2021 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing...